open access

Vol 77, No 5 (2009)
CASE REPORTS
Published online: 2009-08-12
Submitted: 2013-02-22
Get Citation

Neurofibromatosis type 1 in an adult diagnosed by a pulmonologist

Agnieszka Gawlewicz-Mroczka, Lucyna Mastalerz, Ewa Niżankowska-Mogilnicka
Pneumonol Alergol Pol 2009;77(5):474-478.

open access

Vol 77, No 5 (2009)
CASE REPORTS
Published online: 2009-08-12
Submitted: 2013-02-22

Abstract

Neurofibromatosis type 1 (NF1), referred to as von Recklinghausen’s disease, is a genetic disorder triggered by mutation of the NF1 gene, resulting in a lack of neurofibromin, which leads to abnormalities found in the peripheral nervous system and central nervous system, as well as in other organs. The disease is diagnosed early, usually in childhood by pediatricians. However, in some cases, the disease is clinically silent and remains undiagnosed or is recognized in the late adulthood. We report a case study of a 32-year-old female, who was referred to the pulmunologist with a suspicion of a lung tumor. The patient was admitted to the Pulmonology Department to investigate further the subpleural mass localized in the left lung found by chance in a chest X-ray. Physical examination revealed café-au-lait spots on her skin, several subcutaneous nodules which were confirmed by a histopathology to be consistent with neurofibroma. Further diagnostic testing, such as chest CT, PET and ophthalmological examination, led to diagnosis of neurofibromatosis type 1 with pulmonary involvement.

Abstract

Neurofibromatosis type 1 (NF1), referred to as von Recklinghausen’s disease, is a genetic disorder triggered by mutation of the NF1 gene, resulting in a lack of neurofibromin, which leads to abnormalities found in the peripheral nervous system and central nervous system, as well as in other organs. The disease is diagnosed early, usually in childhood by pediatricians. However, in some cases, the disease is clinically silent and remains undiagnosed or is recognized in the late adulthood. We report a case study of a 32-year-old female, who was referred to the pulmunologist with a suspicion of a lung tumor. The patient was admitted to the Pulmonology Department to investigate further the subpleural mass localized in the left lung found by chance in a chest X-ray. Physical examination revealed café-au-lait spots on her skin, several subcutaneous nodules which were confirmed by a histopathology to be consistent with neurofibroma. Further diagnostic testing, such as chest CT, PET and ophthalmological examination, led to diagnosis of neurofibromatosis type 1 with pulmonary involvement.
Get Citation

Keywords

neurofibromatosis type 1; von Recklinghausen' s disease; lung tumor

About this article
Title

Neurofibromatosis type 1 in an adult diagnosed by a pulmonologist

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 5 (2009)

Pages

474-478

Published online

2009-08-12

Bibliographic record

Pneumonol Alergol Pol 2009;77(5):474-478.

Keywords

neurofibromatosis type 1
von Recklinghausen's disease
lung tumor

Authors

Agnieszka Gawlewicz-Mroczka
Lucyna Mastalerz
Ewa Niżankowska-Mogilnicka

References (12)
  1. Zajączek S. van de Wetering T. Nerwiakowłókniakowatość typu 1 (NF1, choroba von Recklinghausena). Postępy Nauk Med. 2008; 8: 510–514.
  2. Huson SM, Korf B. Phakomatoses. In: Emery’s and Rimon’s principles and Practice of Medical Genetics, t. III. Churchill-Livingstone, London 2002: 3162–3202.
  3. Bernards A. Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1995; 1242(1): 43–59.
  4. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet. 1995; 11(1): 90–92.
  5. Sørensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986; 314(16): 1010–1015.
  6. Walker L, Thompson D, Easton D, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006; 95(2): 233–238.
  7. Gutmann D. The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2. JAMA: The Journal of the American Medical Association. 1997; 278(1): 51–58.
  8. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007; 44(2): 81–88.
  9. Ryu JH, Parambil JG, McGrann PS, et al. Lack of evidence for an association between neurofibromatosis and pulmonary fibrosis. Chest. 2005; 128(4): 2381–2386.
  10. Zamora AC, Collard HR, Wolters PJ, et al. Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J. 2007; 29(1): 210–214.
  11. Shimizu K, Okita R, Uchida Y, et al. Long survival after resection for lung metastasis of malignant peripheral nerve sheath tumor in neurofibromatosis 1. Ann Thorac Cardiovasc Surg. 2008; 14(5): 322–324.
  12. Mason RJ, Broaddus VC, Murray JF, Nadel JA. Neurofibromatosis. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA. ed. Murray and Nadel’s textbook of respiratory medicine. Wyd. 4, t. II. Elsevier Saunders, Pensylwania 2005: 1670.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl